Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 3295618, 7 pages
http://dx.doi.org/10.1155/2016/3295618
Review Article

FSGS Recurrence in Adults after Renal Transplantation

Department of Internal Medicine IV-Nephrology and Hypertension, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria

Received 25 December 2015; Accepted 27 March 2016

Academic Editor: Björn Meijers

Copyright © 2016 Michael Rudnicki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. D. D'Agati, F. J. Kaskel, and R. J. Falk, “Focal segmental glomerulosclerosis,” The New England Journal of Medicine, vol. 365, no. 25, pp. 2398–2411, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Kitiyakara, P. Eggers, and J. B. Kopp, “Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States,” American Journal of Kidney Diseases, vol. 44, no. 5, pp. 815–825, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. M. J. Chun, S. M. Korbet, M. M. Schwartz, and E. J. Lewis, “Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants,” Journal of the American Society of Nephrology, vol. 15, no. 8, pp. 2169–2177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. J. R. Hoyer, R. L. Vernier, J. S. Najarian, L. Raij, R. L. Simmons, and A. F. Michael, “Recurrence of idiopathic nephrotic syndrome after renal transplantation,” The Lancet, vol. 300, no. 7773, pp. 343–348, 1972. View at Publisher · View at Google Scholar · View at Scopus
  5. B. Y. Choy, T. M. Chan, and K. N. Lai, “Recurrent glomerulonephritis after kidney transplantation,” American Journal of Transplantation, vol. 6, no. 11, pp. 2535–2542, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Chadban, “Glomerulonephritis recurrence in the renal graft,” Journal of the American Society of Nephrology, vol. 12, no. 2, pp. 394–402, 2001. View at Google Scholar · View at Scopus
  7. S. Hariharan, M. B. Adams, D. C. Brennan et al., “Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR),” Transplantation, vol. 68, no. 5, pp. 635–641, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Kaplan-Pavlovčič, D. Ferluga, A. Hvala, N. Chwatal-Lakič, A. F. Bren, and A. Vizjak, “Recurrent focal segmental glomerulosclerosis after renal transplantation: is early recurrent proteinuria always a surrogate marker for recurrence of the disease?” Transplantation Proceedings, vol. 34, no. 8, pp. 3122–3124, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-W. Chang, V. Pardo, J. Sageshima et al., “Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis,” Transplantation, vol. 93, no. 12, pp. 1238–1244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. C. Abbott, E. S. Sawyers, J. D. Oliver III et al., “Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States,” American Journal of Kidney Diseases, vol. 37, no. 2, pp. 366–373, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. E. M. Briganti, G. R. Russ, J. J. McNeil, R. C. Atkins, and S. J. Chadban, “Risk of renal allograft loss from recurrent glomerulonephritis,” The New England Journal of Medicine, vol. 347, no. 2, pp. 103–109, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Gallon, J. Leventhal, A. Skaro, Y. Kanwar, and A. Alvarado, “Resolution of recurrent focal segmental glomerulosclerosis after retransplantation,” The New England Journal of Medicine, vol. 366, no. 17, pp. 1648–1649, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. V. J. Savin, R. Sharma, M. Sharma et al., “Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis,” The New England Journal of Medicine, vol. 334, no. 14, pp. 878–883, 1996. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Le Berre, Y. Godfrin, E. Günther et al., “Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats,” The Journal of Clinical Investigation, vol. 109, no. 4, pp. 491–498, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Patrakka, V. Ruotsalainen, P. Reponen et al., “Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the finnish type: role of nephrin,” Transplantation, vol. 73, no. 3, pp. 394–403, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Becker-Cohen, M. Bruschi, C. Rinat et al., “Recurrent nephrotic syndrome in homozygous truncating NPHS2 mutation is not due to anti-podocin antibodies,” American Journal of Transplantation, vol. 7, no. 1, pp. 256–260, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. T. C. Jungraithmayr, K. Hofer, P. Cochat et al., “Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation,” Journal of the American Society of Nephrology, vol. 22, no. 3, pp. 579–585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Weber, O. Gribouval, E. L. Esquivel et al., “NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence,” Kidney International, vol. 66, no. 2, pp. 571–579, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Bertelli, F. Ginevri, G. Caridi et al., “Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin,” American Journal of Kidney Diseases, vol. 41, no. 6, pp. 1314–1321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Wei, H. Trachtman, J. Li et al., “Circulating suPAR in two cohorts of primary FSGS,” Journal of the American Society of Nephrology, vol. 23, no. 12, pp. 2051–2059, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Wei, S. El Hindi, J. Li et al., “Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis,” Nature Medicine, vol. 17, no. 8, pp. 952–960, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Alachkar, G. Gupta, and R. A. Montgomery, “Angiotensin antibodies and focal segmental glomerulosclerosis,” The New England Journal of Medicine, vol. 368, no. 10, pp. 971–973, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. D. S. Charba, R. C. Wiggins, M. Goyal et al., “Antibodies to protein tyrosine phosphatase receptor type O (PTPro) increase glomerular albumin permeability (P(alb)),” American Journal of Physiology—Renal Physiology, vol. 297, no. 1, pp. F138–F144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Musante, G. Candiano, M. Bruschi et al., “Circulating anti-actin and anti-ATP synthase antibodies identify a sub-set of patients with idiopathic nephrotic syndrome,” Clinical and Experimental Immunology, vol. 141, no. 3, pp. 491–499, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Vinai, P. Waber, and M. G. Seikaly, “Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review,” Pediatric Transplantation, vol. 14, no. 3, pp. 314–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. L. J. Hickson, M. Gera, H. Amer et al., “Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence,” Transplantation, vol. 87, no. 8, pp. 1232–1239, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Sener, A. J. Bella, C. Nguan, P. P. W. Luke, and A. A. House, “Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function,” Clinical Transplantation, vol. 23, no. 1, pp. 96–100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Tejani and D. H. Stablein, “Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative study,” Journal of the American Society of Nephrology, vol. 2, supplement, no. 12, pp. S258–S263, 1992. View at Google Scholar · View at Scopus
  29. S. Weber and B. Tönshoff, “Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects,” Transplantation, vol. 80, supplement 1, pp. S128–S134, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Dall'Amico, G. Ghiggeri, M. Carraro et al., “Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children,” American Journal of Kidney Diseases, vol. 34, no. 6, pp. 1048–1055, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Fujisawa, K. Iijima, T. Ishimura et al., “Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation,” Pediatric Nephrology, vol. 17, no. 3, pp. 165–168, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. W. Y. Ding, A. Koziell, H. J. McCarthy et al., “Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence,” Journal of the American Society of Nephrology, vol. 25, no. 6, pp. 1342–1348, 2014. View at Publisher · View at Google Scholar
  33. R. Raafat, L. B. Travis, A. Kalia, and S. Diven, “Role of transplant induction therapy on recurrence rate of focal segmental glomerulosclerosis,” Pediatric Nephrology, vol. 14, no. 3, pp. 189–194, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Pascual, J. D. Mezrich, A. Djamali et al., “Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation,” Transplantation, vol. 83, no. 11, pp. 1429–1434, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. P.-T. T. Pham and P.-C. T. Pham, “The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence,” Nephrology Dialysis Transplantation, vol. 27, no. 7, pp. 2965–2971, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. V. D. D'Agati, A. B. Fogo, J. A. Bruijn, and J. C. Jennette, “Pathologic classification of focal segmental glomerulosclerosis: a working proposal,” American Journal of Kidney Diseases, vol. 43, no. 2, pp. 368–382, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Canaud, D. Dion, J. Zuber et al., “Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS),” Nephrology Dialysis Transplantation, vol. 25, no. 4, pp. 1321–1328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. D. H. T. Ijpelaar, A. B. Farris, N. Goemaere et al., “Fidelity and evolution of recurrent FSGS in renal allografts,” Journal of the American Society of Nephrology, vol. 19, no. 11, pp. 2219–2224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Cravedi, J. B. Kopp, and G. Remuzzi, “Recent progress in the pathophysiology and treatment of FSGS recurrence,” American Journal of Transplantation, vol. 13, no. 2, pp. 266–274, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. C. Morath, C. Wei, S. Macher-Goeppinger, V. Schwenger, M. Zeier, and J. Reiser, “Management of severe recurrent focal segmental glomerulosclerosis through circulating soluble urokinase receptor modification,” American Journal of Therapeutics, vol. 20, no. 2, pp. 226–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Beaudreuil, X. Zhang, F. Kriaa et al., “Protein A immunoadsorption cannot significantly remove the soluble receptor of urokinase from sera of patients with recurrent focal segmental glomerulosclerosis,” Nephrology Dialysis Transplantation, vol. 29, no. 2, pp. 458–463, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Thunø, B. MacHo, and J. Eugen-Olsen, “suPAR: the molecular crystal ball,” Disease Markers, vol. 27, no. 3-4, pp. 157–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. R. J. H. Maas, J. F. M. Wetzels, and J. K. J. Deegens, “Serum-soluble urokinase receptor concentration in primary FSGS,” Kidney International, vol. 81, no. 10, pp. 1043–1044, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. S. S. Hayek, S. Sever, Y. A. Ko et al., “Soluble urokinase receptor and chronic kidney disease,” The New England Journal of Medicine, vol. 373, no. 20, pp. 1916–1925, 2015. View at Publisher · View at Google Scholar
  45. H. Trachtman, “suPAR and team nephrology,” BMC Medicine, vol. 12, article 82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Delville, T. K. Sigdel, C. Wei et al., “A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation,” Science Translational Medicine, vol. 6, no. 256, p. 256ra136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. S. W. Zimmerman, “Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis,” Nephron, vol. 40, no. 2, pp. 241–245, 1985. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Ponticelli, “Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation,” Nephrology Dialysis Transplantation, vol. 25, no. 1, pp. 25–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. R. Y. Gohh, A. F. Yango, P. E. Morrissey et al., “Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients,” American Journal of Transplantation, vol. 5, no. 12, pp. 2907–2912, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. H. Hubsch, B. Montané, C. Abitbol et al., “Recurrent focal glomerulosclerosis in pediatric renal allografts: the miami experience,” Pediatric Nephrology, vol. 20, no. 2, pp. 210–216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Fencl, E. Šimková, K. Vondrák et al., “Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports,” Transplantation Proceedings, vol. 39, no. 10, pp. 3488–3490, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Belson, P. D. Yorgin, A. Y. Al-Uzri, O. Salvatierra, J. Higgins, and S. R. Alexander, “Long-term plasmapheresis and protein A column treatment of recurrent FSGS,” Pediatric Nephrology, vol. 16, no. 12, pp. 985–989, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Salomon, M.-F. Gagnadoux, and P. Niaudet, “Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children,” Transplantation, vol. 75, no. 6, pp. 810–814, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. R. H. Raafat, A. Kalia, L. B. Travis, and S. C. Diven, “High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children,” American Journal of Kidney Diseases, vol. 44, no. 1, pp. 50–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Fornoni, J. Sageshima, C. Wei et al., “Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis,” Science Translational Medicine, vol. 3, no. 85, Article ID 85ra46, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. D. Pescovitz, B. K. Book, and R. A. Sidner, “Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment,” The New England Journal of Medicine, vol. 354, no. 18, pp. 1961–1963, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. C. E. Araya and V. R. Dharnidharka, “The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review,” Journal of Transplantation, vol. 2011, Article ID 374213, 7 pages, 2011. View at Publisher · View at Google Scholar
  58. P. Cravedi, P. Ruggenenti, and G. Remuzzi, “Low-dose rituximab for posttransplant recurrent membranous nephropathy,” American Journal of Transplantation, vol. 10, no. 5, p. 1336, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Tsagalis, E. Psimenou, L. Nakopoulou, and A. Laggouranis, “Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation,” Artificial Organs, vol. 35, no. 4, pp. 420–425, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. D. Hristea, K. Hadaya, N. Marangon et al., “Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab,” Transplant International, vol. 20, no. 1, pp. 102–105, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Mizuiri, T. Kawamura, M. Miyagi et al., “Post-transplant early recurrent proteinuria in patients with focal glomerulosclerosis—Angiotensin II immunostaining and treatment outcome,” Clinical Transplantation, vol. 19, supplement 14, pp. 12–19, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Montagnino, A. Tarantino, G. Banfi, M. Maccario, L. Costamagna, and C. Ponticelli, “Double recurrence of FSGS after two renal transplants with complete regression after plasmapheresis and ACE inhibitors,” Transplant International, vol. 13, no. 2, pp. 166–168, 2000. View at Publisher · View at Google Scholar · View at Scopus
  63. V. Freiberger, K. Amann, U. Heemann, and H. Frank, “Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation,” Transplant International, vol. 22, no. 11, pp. 1110–1113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. V. J. Savin, E. T. McCarthy, R. Sharma, D. Charba, and M. Sharma, “Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity,” Translational Research, vol. 151, no. 6, pp. 288–292, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. C.-C. Yu, A. Fornoni, A. Weins et al., “Abatacept in B7-1-positive proteinuric kidney disease,” The New England Journal of Medicine, vol. 369, no. 25, pp. 2416–2423, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. E. H. Garin, J. Reiser, G. Cara-Fuentes et al., “Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis,” Pediatric Nephrology, vol. 30, no. 3, pp. 469–477, 2015. View at Google Scholar
  67. N. Alachkar, N. Carter-Monroe, and J. Reiser, “Abatacept in B7-1-positive proteinuric kidney disease,” The New England Journal of Medicine, vol. 370, no. 13, pp. 1263–1264, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. O. Alkandari, N. Nampoory, P. Nair et al., “Recurrent focal segmental glomerulosclerosis and abatacept: case report,” Experimental and Clinical Transplantation, 2014. View at Publisher · View at Google Scholar
  69. M. A. Baum, D. M. Stablein, V. M. Panzarino, A. Tejani, W. E. Harmon, and S. R. Alexander, “Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis,” Kidney International, vol. 59, no. 1, pp. 328–333, 2001. View at Publisher · View at Google Scholar · View at Scopus
  70. E. J. Nehus, J. W. Goebel, P. S. Succop, and E. C. Abraham, “Focal segmental glomerulosclerosis in children: multivariate analysis indicates that donor type does not alter recurrence risk,” Transplantation, vol. 96, no. 6, pp. 550–554, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. D. M. Cibrik, B. Kaplan, D. A. Campbell, and H.-U. Meier-Kriesche, “Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis,” American Journal of Transplantation, vol. 3, no. 1, pp. 64–67, 2003. View at Publisher · View at Google Scholar · View at Scopus